We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.75B
AUM Growth
-$39.4M
Cap. Flow
-$636M
Cap. Flow %
-11.06%
Top 10 Hldgs %
22.09%
Holding
798
New
336
Increased
102
Reduced
128
Closed
170

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$72.3M
2
VYX icon
NCR Voyix
VYX
+$64.1M
3
HUM icon
Humana
HUM
+$64M
4
CNQR
CONCUR TECHNOLOGIES INC
CNQR
+$63.4M
5
TSM icon
TSMC
TSM
+$62.3M

Sector Composition

Rank Sector Weight
1 Healthcare 11.85%
2 Consumer Discretionary 11.63%
3 Consumer Staples 10.69%
4 Industrials 10.3%
5 Technology 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRW
1
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
$164M 2.86%
1,599,148
+200,448
+14% +$20.5M
NLSN
2
DELISTED
Nielsen Holdings plc
NLSN
$158M 2.74%
3,528,014
+537,314
+18% +$23M
COV
3
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$142M 2.47%
1,391,000
-129,000
-8% -$12.4M
PL
4
DELISTED
PROTECTIVE LIFE CORP
PL
$135M 2.35%
1,936,786
+292,507
+18% +$20.4M
CFN
5
DELISTED
CAREFUSION CORPORATION
CFN
$129M 2.24%
+2,168,433
New +$125M
DTV
6
DELISTED
DIRECTV COM STK (DE)
DTV
$115M 1.99%
1,322,012
+314,000
+31% +$27M
HUM icon
7
Humana
HUM
$44.1B
$109M 1.9%
761,688
-468,366
-38% -$64M
AGN
8
DELISTED
Allergan Inc
AGN
$97.8M 1.7%
460,000
+360,000
+360% +$71.6M
SIAL
9
DELISTED
SIGMA - ALDRICH CORP
SIAL
$96.5M 1.68%
703,195
+513,195
+270% +$69.7M
SCHW
10
Charles Schwab
SCHW
$187B
$94.3M 1.64%
3,122,872
+2,672
+0.1% +$75.9K
TWC
11
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$89.4M 1.55%
588,022
MU icon
12
Micron Technology
MU
$996B
$85.1M 1.48%
2,429,532
+121,211
+5% +$4.01M
CVD
13
DELISTED
COVANCE INC.
CVD
$84.1M 1.46%
+810,100
New +$75.9M
ASH icon
14
Ashland
ASH
$3.32B
$82.3M 1.43%
1,404,835
-403,798
-22% -$21.8M
EBAY icon
15
eBay
EBAY
$48.9B
$79.4M 1.38%
3,362,114
+492,887
+17% +$11.2M
FDO
16
DELISTED
FAMILY DOLLAR STORES
FDO
$78.3M 1.36%
988,280
+509,526
+106% +$40M
AAL icon
17
American Airlines Group
AAL
$10.6B
$74.8M 1.3%
1,394,431
+547,630
+65% +$23.6M
CBST
18
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$59.7M 1.04%
+592,729
New +$46.1M
ROC
19
DELISTED
ROCKWOOD HLDGS INC
ROC
$57M 0.99%
722,890
+572,890
+382% +$44.2M
DRC
20
DELISTED
DRESSER-RAND GROUP INC
DRC
$56.6M 0.98%
691,695
+581,189
+526% +$47.3M
HSP
21
DELISTED
HOSPIRA INC
HSP
$55.1M 0.96%
899,819
-141,942
-14% -$8.01M
BFH icon
22
Bread Financial
BFH
$4.44B
$54.5M 0.95%
238,785
+31,431
+15% +$6.88M
PEP icon
23
PepsiCo
PEP
$189B
$52M 0.9%
+549,731
New +$52.7M
WMT icon
24
Walmart Inc
WMT
$892B
$45.3M 0.79%
1,581,603
+564,228
+55% +$15.2M
HCBK
25
DELISTED
HUDSON CITY BANCORP INC
HCBK
$45.2M 0.79%
4,463,300
+853,100
+24% +$8.23M

Similar funds

UBS O'Connor's Q4 2014 Portfolio in Review

As of Q4 2014, UBS O'Connor held 798 positions worth $5.75B, down 0.68% from $5.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

UBS O'Connor withdrew a net $636M in Q4 2014, closing 170 positions and reducing 128 holdings. Its most notable exit was NCR Voyix, an estimated $64.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in CAREFUSION CORPORATION worth $129M.

  • UBS O'Connor's largest Q4 2014 buy was CAREFUSION CORPORATION: 2,168,433 shares worth $129M.
  • UBS O'Connor added most to Allergan Inc in Q4 2014, an estimated $71.6M increase.
  • UBS O'Connor's biggest Q4 2014 reduction was Alibaba, cutting an estimated $72.3M.
  • UBS O'Connor fully exited NCR Voyix in Q4 2014, selling an estimated $64.1M.
  • UBS O'Connor's ten largest holdings make up 22% of its $5.75B portfolio in Q4 2014.
  • UBS O'Connor opened 336 new positions and closed 170 in Q4 2014.
  • UBS O'Connor's portfolio value fell 0.68% quarter-over-quarter to $5.75B.

Based on UBS O'Connor's 13F filing for Q4 2014, filed 13 Feb 2015.